Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Am J Transplant. 2020 Feb 20;20(6):1513–1526. doi: 10.1111/ajt.15777

Figure 5. rhC1INH treatment limits systemic levels of TNFα and MCP-1 in BD donors.

Figure 5.

Plasma levels of (a) IL-6, (b) IL-8, (c) TNFα, and (d) MCP-1 in donors from G1 – vehicle (n=3), G2 – rhC1INH + heparin (n=3) and G3 – heparin (n=2). Data expressed as fold change relative to baseline value, significance is calculated by one-way ANOVA and Bonferroni’s post-hoc correction (*p<0.05).